Phase II Study of Temozolomide (Temodal) in Children Over 1 Year of Age With Relapsed or Refractory High Risk Neuroblastoma
Phase of Trial: Phase II
Latest Information Update: 16 Sep 2013
At a glance
- Drugs Temozolomide (Primary)
- Indications Neuroblastoma
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 16 Sep 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 24 Aug 2006 New trial record.